Medical Devices Company Investment Opportunity in Secunderabad, India

- We are a startup planning to manufacture blood sugar measuring machines.

- The business has not yet started operations and have been involved in research and development for the past 5+ years.

- We have always been dedicated to pushing the boundaries of innovation in healthcare.

- Over the years, we have seen remarkable success in developing cutting-edge solutions that have improved patient care, streamlined operations, and driven efficiency across the industry.

- Today, we stand on the cusp of a new.

Breakthrough - a product that has the potential to revolutionize healthcare delivery.

We are thrilled to introduce you to our latest innovation non-invasive blood glucose meters.

- This revolutionary product is poised to address the critical challenges within the healthcare sector including no blood, no pain, no needle, no prick, no spread of infection, and no bio-contamination.

- Our team of expert researchers, engineers, and healthcare professionals has worked tirelessly to develop the product, which is designed to make the life of a diabetic patient more comfortable with no pain and multiple tests at no cost.

- We have tied up with IIT Hyderabad and have been incubated by CFHE.

- We have finished the final testing stage and can launch the product within a year.

- Manufacturing will be done on a contract basis.

- Promoters have over 15 years of experience in the healthcare industry.

- The business has a registration certificate and the other licenses are yet to be applied for.

We have a patented blood sugar testing device which can test blood sugar without having to draw blood from the body it is non-invasive.

The assets include the prototype with the technology worth INR 50 crores. The intangible asset includes the patent worth almost INR 58 crores.

Rental premises of 2,000 Sq Ft for fabrication and testing. The facility is located in Trimulgherry.

- The business is self-funded.

- There are no loans or debts in the business.

- The business has three founder directors and an appointed director to manage R&D activity. They all have equal shareholding.